Search
for
Sort by
Research 151–180 of 1000+
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- JAK Inhibitors for Treatment of Alopecia Areata
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- The Role of Janus Kinase Inhibitors in Dermatology
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Janus Kinase inhibitors in dermatology: a review